tiprankstipranks
Blurbs

Analysts Are Bullish on Top Healthcare Stocks: Aeterna Zentaris (AEZS), Portage Biotech Inc (PRTG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aeterna Zentaris (AEZSResearch Report) and Portage Biotech Inc (PRTGResearch Report) with bullish sentiments.

Aeterna Zentaris (AEZS)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Aeterna Zentaris today and set a price target of $1.50. The company’s shares closed last Thursday at $0.21, close to its 52-week low of $0.16.

According to TipRanks.com, Selvaraju is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -37.3% and a 19.3% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Santhera Pharmaceuticals Holding AG, Oramed Pharmaceuticals, and Oncternal Therapeutics.

Currently, the analyst consensus on Aeterna Zentaris is a Moderate Buy with an average price target of $1.50.

See today’s best-performing stocks on TipRanks >>

Portage Biotech Inc (PRTG)

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Portage Biotech Inc, with a price target of $32.00. The company’s shares closed last Thursday at $7.61, close to its 52-week low of $4.62.

According to TipRanks.com, Burns is ranked 0 out of 5 stars with an average return of -18.1% and a 28.4% success rate. Burns covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Black Diamond Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Portage Biotech Inc with a $32.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AEZS:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed